Lund, Sweden

Jimmy Eklund

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sony Group Corporation. Active years: 2022.


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jimmy Eklund in Blood Glucose Monitoring

Introduction

Jimmy Eklund is an innovative inventor based in Lund, Sweden. He has made significant contributions to the field of medical technology, particularly in the area of blood glucose monitoring. His work focuses on improving the accuracy and efficiency of glucose level assessments for individuals.

Latest Patents

Eklund holds a patent for a method and device for blood glucose level monitoring. This innovative method involves receiving a first glucose value measured in a body fluid other than blood, which represents the individual's blood glucose level with a first delay. The process also includes receiving and analyzing the individual's speech to determine a supplementary glucose value that reflects the blood glucose level with a shorter delay than the first. This unique approach enhances the monitoring process by integrating speech analysis.

Career Highlights

Eklund's career is marked by his dedication to advancing medical technology. His patent demonstrates his commitment to finding new solutions for health monitoring. Working at Sony Group Corporation, he has been able to leverage the company's resources and expertise to further his research and development efforts.

Collaborations

Eklund collaborates with talented colleagues, including Jim Rasmusson and Peter C Karlsson. Their combined expertise contributes to the innovative projects they undertake at Sony Group Corporation.

Conclusion

Jimmy Eklund's work in blood glucose monitoring exemplifies the intersection of technology and healthcare. His innovative methods have the potential to significantly improve the lives of individuals managing diabetes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…